Feprazone
Code | Size | Price |
---|
TAR-T7722-5mg | 5mg | £111.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T7722-1mL | 1 mL * 10 mM (in DMSO) | £122.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T7722-10mg | 10mg | £129.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T7722-25mg | 25mg | £173.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T7722-50mg | 50mg | £221.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T7722-100mg | 100mg | £284.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Feprazone possesses anti-inflammatory and antiadipogenic properties. Feprazone can be used in studies about the treatment of joint and muscular pain.
CAS:
30748-29-9
Formula:
C20H20N2O2
Molecular Weight:
320.392
Purity:
0.98
SMILES:
CC(C)=CCC1C(=O)N(N(C1=O)c1ccccc1)c1ccccc1
References
Spahn H, Mutschler E. The influence of aluminium hydroxide on the bioavailability of feprazone. Single dose study. Arzneimittelforschung. 1985;35(1):167-9. PubMed PMID: 4039147.
Berry DJ, Crome P, Corless D, Parke DV. The pharmacokinetics of single oral doses of feprazone in healthy volunteers and elderly patients. Xenobiotica. 1991 Sep;21(9):1211-6. PubMed PMID: 1788989.
Berry D, Parke DV. The disposition of feprazone and its hydroxylated metabolite in human volunteers. Xenobiotica. 1988 Jul;18(7):857-68. PubMed PMID: 3176523.
Meloni T, Forteleoni G, Serra M, Daniotti S, Negri L, Giuntini P, Canepa L, Gaetani GF. Feprazone: absence of hemolytic effects in glucose-6-phosphate dehydrogenase-deficient subjects. J Clin Pharmacol. 1982 Aug-Sep;22(8-9):418-20. PubMed PMID: 7130431.